Publication Name	World Journal of Clinical Oncology
Manuscript ID	88665
Country	Greece

Received	2023-10-05 08:25
Peer-Review Started	2023-10-05 08:26
To Make the First Decision
Return for Revision	2023-11-09 04:12
Revised	2023-11-09 09:02
Second Decision	2023-11-24 06:31
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2023-12-01 07:20
Articles in Press	2023-12-01 07:20
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-12-18 11:56
Publish the Manuscript Online	2023-12-22 03:31

ISSN	2218-4333 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Surgery
Manuscript Type	Review
Article Title	Update on current diagnosis and management of anaplastic thyroid carcinoma
Manuscript Source	Invited Manuscript
All Author List	Efstathios T Pavlidis, Ioannis N Galanis and Theodoros E Pavlidis
Funding Agency and Grant Number
Corresponding Author	Theodoros E Pavlidis, Doctor, PhD, Emeritus Professor, Surgeon, 2nd Propedeutic Department of Surgery, Hippokration General Hospital, School of Medicine, Aristotle University of Thessaloniki, Konstantinoupoleos 49, Thessaloniki 54642, Greece. pavlidth@auth.gr
Key Words	Thyroid diseases; Thyroid cancers; Anaplastic carcinoma; Undifferentiated carcinoma; Neck mass; Aggressive malignancies
Core Tip	Anaplastic thyroid carcinoma is uncommon but one of the most lethal neoplasms. The optimal management remains unclear. The addition of novel targeted therapy and immunotherapy to the traditional management of surgery, radiation and chemotherapy has improved the outcomes. Multimodality management and the emerging use of individualized treatment based on novel therapeutic agents offers promising results. However, further research efforts involving the molecular microenvironment and biological drivers should be made.
Publish Date	2023-12-22 03:31
Citation	Pavlidis ET, Galanis IN, Pavlidis TE. Update on current diagnosis and management of anaplastic thyroid carcinoma. World J Clin Oncol 2023; 14(12): 570-583
URL	https://www.wjgnet.com/2218-4333/full/v14/i12/570.htm
DOI	https://dx.doi.org/10.5306/wjco.v14.i12.570

Full Article (PDF)	WJCO-14-570-with-cover.pdf
Full Article (Word)	WJCO-14-570.docx
Manuscript File	88665_Auto_Edited-JLW.docx
Answering Reviewers	88665-Answering reviewers.pdf
Audio Core Tip	88665-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	88665-Conflict-of-interest statement.pdf
Copyright License Agreement	88665-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	88665-Language certificate.pdf
Peer-review Report	88665-Peer-review(s).pdf
Scientific Misconduct Check	88665-Bing-Wang JJ-2.png
Scientific Editor Work List	88665-Scientific editor work list.pdf